Senate passes legislation to ensure no halt in FDA reviews

WASHINGTON — Drug and medical device makers would pay higher user fees under legislation the Senate approved and sent to the president on Thursday. The revenue raised would help pay for the government reviews required to bring their products to the market.

Senate Majority Leader Mitch McConnell, R-Ky., said the bill's passage will ensure the review of medical devices and medicine won't come to a screeching halt in a few weeks. The current law governing these fees expires Sept. 30.

The legislation cleared the Senate on a vote of 94-1. The bill also includes measures to help an array of patient groups around the country such as children with cancer and people with hearing problems.

The legislation rejects the Trump administration's recommendation to fund FDA reviews entirely through user fees. Doing so would have upended several months' worth of negotiations over the fees, which will generate between $8 billion and $9 billion over five years. The administration had argued that "in an era of renewed fiscal restraint, industries that benefit directly from FDA's work should pay for it."

The House approved the bill last month. It is one of the final measures the Senate planned to consider before lawmakers leave Washington for their August recess.

The legislation covers much more than user fees. In a bid to improve treatment options for children in cancer, the bill requires companies developing cancer drugs for adults to also study their suitability for children when there is an indication it could help kids as well.

Patient groups say there is little market incentive for the pharmaceutical industry to develop pediatric oncology drugs because the population is small compared to the adult population. Most drugs used for pediatric cancer were specifically approved for adults, and the advocacy group Kids v Cancer reports that there are almost 900 drugs in the adult cancer pipeline, but only a handful in development for children.

The bill also instructs the FDA to revise its regulations to establish a category of hearing aids that could be sold without a prescription. The idea behind the change is to give people with mild to moderate hearing loss greater access to hearing aids in the same way that people can buy reading glasses. Supporters said the measure will drive down the cost of hearing aids.

The lone "no" vote came from Vermont Sen. Bernie Sanders. Spokesman Josh Miller-Lewis said Sanders voted no because the bill "does nothing to lower drug prices and is a giveaway to the pharmaceutical industry."

Still, other lawmakers cited aspects of the bill that they said would boost competition by speeding reviews of certain generic drug applications.

Sen. Ron Johnson, R-Wisc., lifted objections to taking up the bill after securing a vote for separate legislation aimed at allowing terminally ill patients to get investigational medical treatments where no alternative exists. Johnson's legislation also passed the Senate on Thursday.

While the FDA user fee bill had widespread support, the Project on Government Oversight, a watchdog group, said Congress should rethink a system that leaves the FDA so beholden to industry for funding and the terms of the funding.

You may also interested in

Uber fires autonomous car researcher involved in lawsuit

May 30, 2017

Uber has followed through on threats to fire a star autonomous car researcher whose hiring touched off a bitter legal fight with Waymo, the former self-driving car arm of Google

Politicians blocking people on social media ignites debate

Aug 10, 2017

Politicians at all levels are embracing social media to discuss government business, and their ability to block people from their accounts has led to debate about whether that violates free speech rights

TV executive predicts 500-show bubble destined to deflate

Aug 9, 2016

Television viewers know there's a mind-boggling array of shows to attempt to watch, but FX Networks chief executive John Landgraf predicts that change is coming

People also read these

Uber fires autonomous car researcher involved in lawsuit

May 30, 2017

Uber has followed through on threats to fire a star autonomous car researcher whose hiring touched off a bitter legal fight with Waymo, the former self-driving car arm of Google

Politicians blocking people on social media ignites debate

Aug 10, 2017

Politicians at all levels are embracing social media to discuss government business, and their ability to block people from their accounts has led to debate about whether that violates free speech rights

TV executive predicts 500-show bubble destined to deflate

Aug 9, 2016

Television viewers know there's a mind-boggling array of shows to attempt to watch, but FX Networks chief executive John Landgraf predicts that change is coming

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH